Infertility Clinical Trial
— INFEXOOfficial title:
Assessment of the Sexuality of the Infertile Couple: Prospective Cohort Study
| NCT number | NCT04539392 |
| Other study ID # | NIMAO/2019-2/SH-01 |
| Secondary ID | |
| Status | Recruiting |
| Phase | |
| First received | |
| Last updated | |
| Start date | June 28, 2022 |
| Est. completion date | June 2024 |
The study hypothesis is that infertile couples experience an impact of their sexuality impacted during the diagnostic process carried out as part of the medically assisted procreation assessment, and also by the announcement of the possible cause of the couple's infertility. It is also conceivable that a disorder of the couple's sexuality forms the origin of, or is a contributor to, infertility.
| Status | Recruiting |
| Enrollment | 60 |
| Est. completion date | June 2024 |
| Est. primary completion date | June 2024 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 18 Years to 60 Years |
| Eligibility | Inclusion Criteria: - Couple in which each of the two partners has signed the consent form which is presented separately and independently of their partner. - The patient must be a member or beneficiary of a health insurance plan - Heterosexual infertile couple (according to the WHO definition) monitored at the Nîmes University Hospital in the urology / gynecology departments. Adult patient (=18 years old) and under 40 years old for women, 60 years old for men Exclusion Criteria: - The subject is participating in a category 1 interventional study, or is in a period of exclusion determined by a previous study - One member of the couple refuses to sign the consent - It is impossible to give the subject informed information - The patient is under safeguard of justice or state guardianship - Patient without good level of written and spoken French |
| Country | Name | City | State |
|---|---|---|---|
| France | CHU de Nimes | Nîmes |
| Lead Sponsor | Collaborator |
|---|---|
| Centre Hospitalier Universitaire de Nimes |
France,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Sexuality of the female of the couple | Female sexual function index: The total score is between 2 and 36 with sexual dysfunction indicated for scores below 26.55 | 2 weeks after inclusion (start of MAP) | |
| Primary | Sexuality of the female of the couple | Female sexual function index: The total score is between 2 and 36 with sexual dysfunction indicated for scores below 26.55 | 1 month after ovarian ponction (end of MAP) | |
| Primary | Sexuality of the male of the couple | Male Sexual Health Questionnaire | 2 weeks after inclusion (start of MAP) | |
| Primary | Sexuality of the male of the couple | Male Sexual Health Questionnaire | 1 month after ovarian ponction (end of MAP) | |
| Primary | Ejactulation of the male of the couple | Premature Ejaculation Profile | 2 weeks after inclusion (start of MAP) | |
| Primary | Ejactulation of the male of the couple | Premature Ejaculation Profile | 1 month after ovarian ponction (end of MAP) | |
| Secondary | Sexuality of the female of the couple | Female sexual function index: The total score is between 2 and 36 with sexual dysfunction indicated for scores below 26.55 | 1 month after ovarian ponction (end of MAP) | |
| Secondary | Sexuality of the male of the couple | Male Sexual Health Questionnaire | 1 month after ovarian ponction (end of MAP) | |
| Secondary | Body satisfaction and global self-perception of both members of the couple | Questionnaire de satisfaction corporelle et de perception globale de soi (QSCPGS): total score ranges from -100 to +100. | 2 weeks after inclusion (start of MAP) | |
| Secondary | Body satisfaction and global self-perception of both members of the couple | Questionnaire de satisfaction corporelle et de perception globale de soi (QSCPGS): total score ranges from -100 to +100. | 1 month after ovarian ponction (end of MAP) | |
| Secondary | Relationship satisfaction of both members of the couple | Dyadic Adjustment Scale-16 Distress if score less than 92 and without distress if the score is higher than 107 | 2 weeks after inclusion (start of MAP) | |
| Secondary | Relationship satisfaction of both members of the couple | Dyadic Adjustment Scale-16 Distress if score less than 92 and without distress if the score is higher than 107 | 1 month after ovarian ponction (end of MAP) | |
| Secondary | Self-esteem of both members of the couple | Rosenberg self-esteem scale: The score is between 10 and 40. A score below 25 indicates very low self-esteem. A score between 25 and 31 indicates low self-esteem. A score between 31 and 34 indicates average self-esteem. A score between 34 and 39 indicates strong self-esteem. A score above 39 indicates very high self-esteem. | 2 weeks after inclusion (start of MAP) | |
| Secondary | Self-esteem of both members of the couple | Rosenberg self-esteem scale: The score is between 10 and 40. A score below 25 indicates very low self-esteem. A score between 25 and 31 indicates low self-esteem. A score between 31 and 34 indicates average self-esteem. A score between 34 and 39 indicates strong self-esteem. A score above 39 indicates very high self-esteem. | 1 month after ovarian ponction (end of MAP) |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03607409 -
Role of Inhibin A as Biomarker for Ovarian Response for IVF Treatment
|
||
| Recruiting |
NCT02312076 -
GnRHa for Luteal Phase Support in Long GnRHa Protocol Cycles
|
Phase 4 | |
| Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
| Completed |
NCT03287479 -
Comparison of a Semi-automated Closed Vitrification System (Gavi®) With a Manual Open Vitrification Sytem (Cryotop®)
|
N/A | |
| Terminated |
NCT03522350 -
Randomized Trial Comparing EmbryoScope With EmbryoScope+.
|
N/A | |
| Completed |
NCT04496284 -
Embryo Transfer Outcomes After Vitrification With Slush Nitrogen Compared to Liquid Nitrogen
|
N/A | |
| Completed |
NCT03623659 -
pArtiaL zonA pelluciDa Removal by assisteD hatchINg of Blastocysts
|
N/A | |
| Completed |
NCT03895099 -
New Ovarian Stimulation With Random Start, Use of Progestin Protocol for Oocyte Donors
|
Phase 3 | |
| Active, not recruiting |
NCT04142112 -
Randomized, Standard-Controlled, Study to Evaluate the Ohana IVF Sperm Preparation Kit, SPeRtility IVF Next Generation
|
N/A | |
| Completed |
NCT03152643 -
Cumulative Live Birth Rates After Cleavage-stage Versus Blastocyst-stage Embryo Transfer
|
N/A | |
| Recruiting |
NCT03683771 -
Assessment of Endometrial Pattern and Sub-endometrial Vascularity in ICSI Outcome
|
||
| Recruiting |
NCT03161119 -
Comparing Two Different Embryo Transfer Catheters
|
N/A | |
| Completed |
NCT04108039 -
Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles.
|
N/A | |
| Completed |
NCT03678818 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin A (ICSI-LA)
|
N/A | |
| Completed |
NCT03678610 -
Handling Medium for ICSI With Ionomycin and Latrunculin A
|
N/A | |
| Completed |
NCT03677492 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Cytochalasin D ( ICSI-CD)
|
N/A | |
| Completed |
NCT03678597 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin B ( ICSI-LB)
|
N/A | |
| Completed |
NCT03678571 -
Oocyte Vitrification Aided With Latrunculin A
|
N/A | |
| Completed |
NCT03678558 -
Oocyte Vitrification Aided With Cytochalasin B
|
N/A | |
| Completed |
NCT03678584 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Chaetoglobosin A ( ICSI-CA)
|
N/A |